Lysosomes and Fas-mediated liver cell death
- 13 March 2007
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 403 (1) , 89-95
- https://doi.org/10.1042/bj20061738
Abstract
A number of studies, mostly performed ex vivo, suggest that lysosomes are involved in apoptosis as a result of a release of their cathepsins into the cytosol. These enzymes could then contribute to the permeabilization of the outer mitochondrial membrane; they could also activate effector caspases. The present study aims at testing whether the membrane of liver lysosomes is disrupted during Fas-mediated cell death of hepatocytes in vivo, a process implicated in several liver pathologies. Apoptosis was induced by injecting mice with aFas (anti-Fas antibody). The state of lysosomes was assessed by determining the proportion of lysosomal enzymes (β-galactosidase, β-glucuronidase, cathepsin C and cathepsin B) present in homogenate supernatants, devoid of intact lysosomes, and by analysing the behaviour in differential and isopycnic centrifugation of β-galactosidase. Apoptosis was monitored by measuring caspase 3 activity (DEVDase) and the release of sulfite cytochrome c reductase, an enzyme located in the mitochondrial intermembrane space. Results show that an injection of 10 μg of aFas causes a rapid and large increase in DEVDase activity and in unsedimentable sulfite cytochrome c reductase. This modifies neither the proportion of unsedimentable lysosomal enzyme in the homogenates nor the behaviour of lysosomes in centrifugation. Experiments performed with a lower dose of aFas (5 μg) indicate that unsedimentable lysosomal hydrolase activity increases in the homogenate after injection but with a marked delay with respect to the increase in DEVDase activity and in unsedimentable sulfite cytochrome c reductase. Comparative experiments ex vivo performed with Jurkat cells show an increase in unsedimentable lysosomal hydrolases, but much later than caspase 3 activation, and a release of dipeptidyl peptidase III and DEVDase into culture medium. It is proposed that the weakening of lysosomes observed after aFas treatment in vivo and ex vivo results from a necrotic process that takes place late after initiation of apoptosis.Keywords
This publication has 34 references indexed in Scilit:
- Pharmacological manipulation of cell death: clinical applications in sight?Journal of Clinical Investigation, 2005
- Lysosomes in cell deathOncogene, 2004
- Selective Disruption of Lysosomes in HeLa Cells Triggers Apoptosis Mediated by Cleavage of Bid by Multiple Papain-like Lysosomal CathepsinsJournal of Biological Chemistry, 2004
- Uptake by mouse liver and intracellular fate of plasmid DNA after a rapid tail vein injection of a small or a large volumeThe Journal of Gene Medicine, 2002
- TNF toxicity—Death from caspase or cathepsin, that is the questionHepatology, 2001
- The Pro-Apoptotic Proteins, Bid and Bax, Cause a Limited Permeabilization of the Mitochondrial Outer Membrane That Is Enhanced by CytosolThe Journal of cell biology, 1999
- α‐Tocopheryl succinate‐induced apoptosis in Jurkat T cells involves caspase‐3 activation, and both lysosomal and mitochondrial destabilisationFEBS Letters, 1999
- Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death.The Journal of Experimental Medicine, 1996
- Subcellular Distribution of Sulfite Cytochrome c Reductase in Rat Liver TissueEuropean Journal of Biochemistry, 1971
- Functions of LysosomesAnnual Review of Physiology, 1966